Discontinuation of Medical Cannabis Common in Musculoskeletal Pain

Follow Drugslib on

By Elana Gotkine HealthDay Reporter

Medically reviewed by Carmen Pope, BPharm. Last updated on Aug 27, 2025.

via HealthDay

TUESDAY, Aug. 26, 2025 -- A number of patients with musculoskeletal pain discontinue medical cannabis (MC) within one year, with many discontinuing within the first three months, according to a study published online Aug. 7 in PLOS ONE.

Mohammad Khak, M.D., M.P.H., from the Rothman Institute Foundation for Opioid Research & Education in Philadelphia, and colleagues examined the rates of MC discontinuation and explored factors influencing discontinuation in patients with chronic musculoskeletal pain in a retrospective analysis. The study included 78 patients certified for MC during a two-year period. Patient demographics, pain origin, and Global Physical Health (GPH) and Global Mental Health (GMH) scores were obtained before the intervention, and discontinuation rates were measured at follow-up of three months and one year.

The researchers found that the overall discontinuation rate of MC use was 57.9 percent at one year; within the first three months, 44.7 percent of patients discontinued. There was a significant association for older age with higher discontinuation rates. There was no significant difference in pain origin categories for those who discontinued and continued MC use. Low back pain was reported by a higher proportion of patients in the discontinued group. Baseline GPH and GMH scores did not differ significantly between the groups.

"These findings suggest that while MC may offer benefits for some patients, further research is needed to better understand the long-term effects of MC on pain management and patient satisfaction, as well as the factors influencing treatment adherence," the authors write.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2025-08-27 12:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords